Inflammatory Bowel Disease Drugs Market Analysis
The global Inflammatory Bowel Disease (IBD) Drugs Market, valued at USD 21.15 billion in 2023, is expected to reach USD 27.65 billion by 2031, growing at a compound annual growth rate (CAGR) of 3.47% during the forecast period from 2024 to 2031.
Inflammatory bowel disease, which includes Crohn's disease and ulcerative colitis, is a chronic...
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian